• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number TABLETOP
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problems Hemorrhage/Bleeding (1888); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 10/27/2020
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A customer reported that during a pars plan vitrectomy, removal of three piece intraocular lens implant (iol), and placement of an anterior chamber iol procedure, in the right eye, the flow of irrigation did not increase and as a result, the eye became soft and hemorrhaged.Additional information was received reporting the infusion line was primed outside of the eye, inserted into a trocar and visualized in the vitreous cavity in standard fashion.While performing the vitrectomy, the eye became hypotonus and it was apparent the infusion line was not working.Attempts were made to increase the intraocular pressure including raising the infusion cannula and injection of balanced salt solution manually through the trocar, however, in the process, the patient developed a moderate choroidal hemorrhage inferotemporally and superiorly, and a small choroidal hemorrhage superiorly.At this point, the vitrectomy was carefully completed without significant expansion of the choroidal hemorrhages as there was minimal vitreous remaining, and the wounds were closed.Postoperative visit one, the visual acuity was hand motion, which the doctor stated was to be expected as the patient was only count fingers pre-operatively.The patient is reported as stable and the prognosis is good at this point.The intraocular pressure was left at 35 to stabilize the eye.
 
Manufacturer Narrative
Additional information provided in d.10., h.3., h.6., and h.10.The company service representative examined the system and was not able to confirm or replicate the reported event of poor infusion.Unrelated to the reported events, the company service representative replaced the central processing unit (cpu) battery and the l5 solenoid.The system was then tested and met all product specifications.The system manufacturing device history record (dhr) was reviewed.Based on qa assessment, the product met specifications at the time of release.The system was found to meet specifications in relation to the reported events; therefore, the root cause of the reported event cannot be determined conclusively.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSTELLATION VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
MDR Report Key10837659
MDR Text Key216180384
Report Number2028159-2020-00971
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
PMA/PMN Number
K101285
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Type of Report Initial,Followup
Report Date 02/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTABLETOP
Device Catalogue Number8065751150
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/27/2020
Initial Date FDA Received11/13/2020
Supplement Dates Manufacturer Received01/25/2021
Supplement Dates FDA Received02/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age90 YR
-
-